# TachoSil Paediatric Liver Trial (TC-019-IN)

> **NCT00365248** · PHASE3 · COMPLETED · sponsor: **Nycomed** · enrollment: 16 (actual)

## Conditions studied

- Liver Diseases

## Interventions

- **DRUG:** Fibrinogen human (TachoSil)

## Key facts

- **NCT ID:** NCT00365248
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2008-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365248, "TachoSil Paediatric Liver Trial (TC-019-IN)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00365248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*